News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BrachySciences Launches Website Dedicated To Brachytherapy brachysciences.com



3/21/2006 12:38:17 PM

OXFORD, Conn., March 21 /PRNewswire/ -- BrachySciences, a leader in research and development of Prostate Brachytherapy products, has just launched BrachySciences.com, a new web site that provides physicians with up-to-date information on brachytherapy products and services. In addition, BrachySciences.com includes a dedicated patient section that provides educational information regarding prostate cancer as well as various treatment options.

"We recognize the importance of providing our customers with immediate access to information regarding our product portfolio and services," said Jim Matons, President of BrachySciences. "Part of our commitment is to provide a reliable source of information for patients and their families searching for answers regarding prostate cancer and treatment options, as well as clinical data and technical information."

BrachySciences' portfolio of products includes numerous innovative, "first-to-market" products such as Vari-Strand(TM) and SeedLock3 (TM) needles. "Our team is dedicated to product innovation, customer focus and quality excellence," says Matons. "This year we will introduce several new products to the market that will advance the way physicians perform prostate brachytherapy procedures."

Brachytherapy is a minimally invasive procedure that involves the use of radioactive seeds the size of rice grains. Brachytherapy, an out-patient procedure, usually takes only 45 minutes to an hour to perform. Most patients can return to their normal activities within days. The success rates of prostate brachytherapy have compared favorably with success rates of radical prostatectomy and external beam radiation. In comparison studies, prostate brachytherapy has shown to have a favorable side effect profile when compared with other modalities. A recent clinical study conducted by Schiffler Cancer following patients 5 years post brachytherapy treatment found 94% of 512 patients were cancer-free.

BrachySciences is a newly formed organization that is dedicated to improving and expanding the use of brachytherapy implants for the treatment of early stage prostate cancer. BrachySciences markets, sells and distributes radioactive seeds as well as unique delivery systems and ancillary equipment used in brachytherapy implants. BrachySciences is committed to optimizing the quality and efficiency of prostate brachytherapy implants by providing state of the art, quality brachytherapy products, and innovative technologies and services to the physicians and institutions that treat patients diagnosed with prostate cancer.

For complete indications and product information described above, contact BrachySciences at 203-262-0571.

BrachySciences

CONTACT: Lindsey Raymond, lraymond@brachysciences.com; or Summer Sharaf,+1-732-322-6988, ssharaf@agmedcom.com


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES